Formulation containing anti-inflammatory androstane derivatives
US6787532B2 · kind B2 · utility
11Cited by
41References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2002 |
| Grant date | Sep 7, 2004 |
| Priority date | — |
| Expiry date | Feb 4, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.